Sandu Pharmaceuticals Limited

₹36.71As of Sun 8 Nov 2026, 12:00 UTC
BSE:524703Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 2.12%
Div yield 2.72%
ROE 4.12%
Pharmaceutical Preparations
Beta (5Y) 0.37
PE TTM 18.17
TSR TTM (15.83%)
Mkt cap ₹354.7M
ROIC 4.17%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹40
10.02%
255.57%
Hold 7|6|1|12|10
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.38
0.40
0.42
0.41
18.54%
27.85%
37.79%
21.95%
Revenue₹M
40.91
42.72
42.18
42.85
—
3.43%
4.70%
8.53%
Peers (US$3.778M)
Cap (US$)
PE
4.146M
4.302x
Capital
TTM
5Y
10Y
Leveragex
0.292
1.010
0.880
EBIT/Intx
0.542
10.57
6.443
Own earn%
73.37
(121.33)
(98.72)
Sh yield%
33.71
29.61
32.31
Owners
Insiders/Inst%
2.96
31.67
Short interest%
4.43
SBC / revenue%
5.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
5–12
$1 testx
0.1
Incr. ROIC%
12